Extrapolating evidence for molecularly targeted therapies from common to rare cancers: a scoping review of methodological guidance.

In the absence of an established framework, our recommendations for components of extrapolation can be used to guide discussions about interpreting evidence to support extrapolation. The review can inform the development of an extrapolation framework for biomarker-targeted therapies in rare cancers.